The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 10, 2026

Filed:

Oct. 10, 2020
Applicant:

Chengdu Mfs Pharma. Co., Ltd., Chengdu, CN;

Inventors:

Jin Liu, Chengdu, CN;

Wensheng Zhang, Chengdu, CN;

Haijun MA, Chengdu, CN;

Changhua Wang, Chengdu, CN;

Zhenbiao Xie, Chengdu, CN;

Assignee:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 231/14 (2006.01); A61P 23/00 (2006.01); C07D 207/333 (2006.01); C07D 233/64 (2006.01); C07D 249/04 (2006.01); C07D 405/06 (2006.01); C07D 405/12 (2006.01); C07D 409/06 (2006.01); C07D 409/12 (2006.01);
U.S. Cl.
CPC ...
C07D 231/14 (2013.01); A61P 23/00 (2018.01); C07D 207/333 (2013.01); C07D 233/64 (2013.01); C07D 249/04 (2013.01); C07D 405/06 (2013.01); C07D 405/12 (2013.01); C07D 409/06 (2013.01); C07D 409/12 (2013.01);
Abstract

Disclosed in the present invention are a substituted nitrogen heterocyclic compound and anesthetic action thereof. Specifically provided a chemical compound as shown in formula I, a stereoisomer thereof, a pharmaceutically acceptable salt thereof, a solvate thereof, a prodrug thereof, a metabolite thereof or a deuterated derivative thereof. The substituted nitrogen heterocyclic compound provided in the present application has good central nervous system inhibition effects, capable of generating sedative, hypnotic and/or general anesthetic effects, and capable of controlling status epilepticus; said substituted nitrogen heterocyclic compound is also characterized by rapid onset of action and rapid recovery, while maintaining positive anesthetic activity; in addition, said substituted nitrogen heterocyclic compound has almost no inhibitory effect on adrenocortical function, low side effects, and resolves technical difficulties in the art. The present invention provides a new selection for clinical screening and/or preparation of sedative, hypnotic and/or general anesthetic drugs and drugs controlling status epilepticus.


Find Patent Forward Citations

Liu, Jin. (2026). Substituted nitrogen heterocyclic compound and anesthetic effect thereof (U.S. Patent No. 12570612). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12570612

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…